Vecuronium Bromide for Injection Supply

This subcontract for the Department of Defense Medical Supply Chain Pharm FSA involves the supply of Vecuronium Bromide for Injection to prime contractors on DLA supply contracts. The selected provider is responsible for manufacturing or sourcing the active ingredient and processing it into a 10mg freeze-dried powder format. All products must be delivered as finished vials, maintaining stability according to USP Controlled Room Temperature standards and adhering to RP001 DLA Packaging Requirements. To qualify for this opportunity, the contractor must possess FDA registration and the necessary lyophilization equipment. The place of performance is located at Travis AFB, and the response deadline for this requirement is October 5, 2026.